Table 2. Candidate regions and genes selected for QMPSF analysis.
Chromosomal location | Type | Candidate Genes | Pathways | Function | Evidence | Disorder | Selected references |
---|---|---|---|---|---|---|---|
2p16.3 | loss | NRXN1 | synapse formation and maintenance | cell adhesion molecule | CR | ASD, SZ, MR | 1, 4, 7, 8, 10, 38, 39 |
2q12.3-q14.2 | loss/gain | DPP10 | neurotransmission | dipeptidyl peptidase | CR | ASD | 4 |
2q33.3-q34 | loss | ERBB4 | synapse formation and maintenance | NRG1 receptor | CR, M | SZ | 8 |
3p26-p25 | loss/gain | CNTN4 | synapse formation and maintenance | Axon-associated cell adhesion molecule | CR, M | ASD, MR | 40, 41 |
3p26.1-p25.2 | loss | GRM7 | neurotransmission | glutamate receptor | CR | SZ | 8 |
3q26.31 | gain | NLGN1 | synapse formation and maintenance | cell adhesion molecule | CR | MR | 42 |
4p14-q21.1 | gain | GABRG1, GABRA4, GABRA2 | neurotransmission | GABA receptor subunits | CR | ASD | 4, 43 |
5p13 | loss | SLC1A3 | neurotransmission | excitatory amino acid transporter | CR, M | SZ | 8 |
7q31.1 | loss | ST7 | other | tumor suppressor | CR, M | ASD | 4 |
7q35-q36 | loss | CNTNAP2 | synapse formation and maintenance | contactin associated protein | CR, M | ASD, SZ, MR, TS | 44 |
8p22-p11 | loss | NRG1 | synapse formation and maintenance | signaling protein | CR | MR | 45 |
8p23 | gain | DLGAP2 | neurotransmission | associated to NMDA receptor and K+ channels | CR | ASD | 4 |
8q24-qter | gain | PTK2 | neuronal migration and growth | focal adhesion kinase | CR | SZ | 8 |
11q21 | loss | DLG2 | synapse formation and maintenance | synaptic scaffolding protein | CR | SZ | 8 |
12q14.3 | loss | GRIP1 | neurotransmission | glutamate receptor interacting protein | CR | MR | 1, 3 |
15q11-q14 | gain | GABRA5, GABRB3, GABRG3 | neurotransmission | GABA receptor subunits | CR | ASD, MR | 46, 47 |
15q13 | gain | APBA2 | neurotransmission | synaptic exocytosis | CR | ASD, SZ | 6, 10 |
15q13.3 | loss | CHRNA7 | neurotransmission | acetylcholine receptor | CR | MR | 48 |
16p11.2 | loss/gain | DOC2A | neurotransmission | neurotransmitter release regulation | CR | ASD, SZ | 4, 6, 8, 31, 33 |
17q21 | loss/gain | MAPT | other | microtubule associated protein | CR | MR | 28, 30 |
22q11 | loss | PRODH | neuromodulation | proline dehydrogenase | CR, M | ASD, SZ, MR | 19 |
22q13 | loss | SHANK3 | synapse formation and maintenance | synaptic scaffolding protein | CR, M | ASD, MR | 4, 24–26 |
Xp22.3 | loss/gain | NLGN4 | synapse formation and maintenance | cell adhesion molecule | CR, M | ASD, TS, MR | 4, 49–52 |
Xp11.4 | gain | TSPAN7 | neuronal migration and growth | transmembrane component | CR, M | ASD, MR | 4, 27 |
Xp11.4 | loss | CASK | synapse formation and maintenance | synaptic scaffolding protein | CR | MR | 2 |
Xp22.1-p21.3 | loss | IL1RAPL1 | other | interleukin receptor | CR, M | ASD, MR | 4, 53 |
Xq25 | gain | GRIA3 | neurotransmission | Kainate receptor subunit | CR | MR | 29 |
Xq28 | gain | MECP2 | other | methylated CpG binding protein | CR, M | MR | 42, 54 |
CR: Chromosomal rearrangement, M: mutation, TS: Tourette syndrome